GBT009

GBT009 · Garnet BioTherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GBT009, covering 2013-10-24 to 2013-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery [Phase 2]